NCT02268565View on ClinicalTrials.gov

Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Insomnia
Interventions
DRUG

Aspirin

81mg aspirin daily at bedtime over a 2 week period

DRUG

Placebo

pill that looks like aspirin without the effects of aspirin

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02268565 - Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms | Biotech Hunter | Biotech Hunter